Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Financial giants have made a conspicuous bullish move on Abbott Laboratories. Our analysis of options history for Abbott Laboratories (NYSE:ABT) revealed 8 unusual trades.
Delving into the details, we found 50% of traders were bullish, while 37% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $93,318, and 5 were calls, valued at $681,133.
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $100.0 to $115.0 for Abbott Laboratories over the recent three months.
In terms of liquidity and interest, the mean open interest for Abbott Laboratories options trades today is 2972.17 with a total volume of 4,909.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Abbott Laboratories's big money trades within a strike price range of $100.0 to $115.0 over the last 30 days.
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|---|---|---|---|---|---|---|---|---|---|---|
ABT | CALL | SWEEP | NEUTRAL | 07/12/24 | $1.36 | $1.05 | $1.18 | $106.00 | $420.9K | 86 | 403 |
ABT | CALL | TRADE | BULLISH | 08/16/24 | $1.12 | $1.06 | $1.11 | $110.00 | $166.5K | 5.7K | 109 |
ABT | PUT | SWEEP | BEARISH | 07/12/24 | $0.7 | $0.63 | $0.7 | $102.00 | $35.0K | 25 | 20 |
ABT | CALL | SWEEP | BULLISH | 11/15/24 | $1.96 | $1.85 | $1.96 | $115.00 | $34.4K | 1.4K | 4 |
ABT | CALL | SWEEP | BULLISH | 07/12/24 | $1.04 | $1.03 | $1.04 | $106.00 | $32.8K | 86 | 4.2K |
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
After a thorough review of the options trading surrounding Abbott Laboratories, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $123.0.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Abbott Laboratories options trades with real-time alerts from Benzinga Pro.
Posted In: ABT